ID28298A - Komposisi yang mengandung virus dan metode untuk memekatkan preparat-preparat virus - Google Patents

Komposisi yang mengandung virus dan metode untuk memekatkan preparat-preparat virus

Info

Publication number
ID28298A
ID28298A IDW20001574A ID20001574A ID28298A ID 28298 A ID28298 A ID 28298A ID W20001574 A IDW20001574 A ID W20001574A ID 20001574 A ID20001574 A ID 20001574A ID 28298 A ID28298 A ID 28298A
Authority
ID
Indonesia
Prior art keywords
preparates
virus
adapt
composition
methods
Prior art date
Application number
IDW20001574A
Other languages
English (en)
Inventor
Andreas Frei
Henry K H Kwan
Varda E Sandweiss
Gary J Vellekamp
Pui-Ho Yuen
Laureano L Bondoc Jr
Frederick William Porter Iv
John Chu-Tay Tang
Peter Ihnat
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ID28298A publication Critical patent/ID28298A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20001574A 1998-02-17 1999-02-12 Komposisi yang mengandung virus dan metode untuk memekatkan preparat-preparat virus ID28298A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2446298A 1998-02-17 1998-02-17
US7964398A 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
ID28298A true ID28298A (id) 2001-05-10

Family

ID=26698472

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001574A ID28298A (id) 1998-02-17 1999-02-12 Komposisi yang mengandung virus dan metode untuk memekatkan preparat-preparat virus

Country Status (24)

Country Link
EP (4) EP1741777B1 (id)
JP (3) JP4358434B2 (id)
KR (5) KR100862169B1 (id)
CN (2) CN101164623B (id)
AR (3) AR020054A1 (id)
AT (3) ATE371020T1 (id)
AU (1) AU757976B2 (id)
BR (1) BR9908015A (id)
CA (2) CA2723040A1 (id)
CO (1) CO4820440A1 (id)
DE (3) DE69933433T2 (id)
DK (1) DK1054955T3 (id)
ES (2) ES2272053T3 (id)
HU (1) HU226015B1 (id)
ID (1) ID28298A (id)
IL (2) IL137510A0 (id)
MY (1) MY141641A (id)
NO (1) NO20004104L (id)
PE (1) PE20000265A1 (id)
PL (1) PL197747B1 (id)
PT (1) PT1054955E (id)
SK (1) SK11842000A3 (id)
TW (1) TWI232107B (id)
WO (1) WO1999041416A2 (id)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
CN1244215B (zh) 1996-11-20 2010-11-03 荷兰克鲁塞尔公司 改进的腺病毒载体生产和纯化方法
US6689600B1 (en) 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
EP1133316B1 (en) * 1998-11-16 2009-01-21 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
US7456009B2 (en) 2000-03-07 2008-11-25 Merck & Co., Inc. Adenovirus formulations
JP5118798B2 (ja) * 2000-03-07 2013-01-16 メルク・シャープ・エンド・ドーム・コーポレイション アデノウイルス製剤
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
AU2002218535A1 (en) * 2000-12-12 2002-06-24 Japan Tobacco Inc. Pharmaceutical composition containing an active with a hemolytic action and a surfactant
WO2003049763A1 (en) 2001-12-12 2003-06-19 Fh Faulding & Co Limited Composition for the preservation of viruses
US20030153065A1 (en) * 2002-01-14 2003-08-14 Genvec, Inc. Composition and method for maintaining non-enveloped viral vectors
JP2005515245A (ja) * 2002-01-18 2005-05-26 シエーリング アクチエンゲゼルシャフト アデノウィルスの安定化された配合物
DK1780269T3 (da) 2004-02-23 2009-10-12 Crucell Holland Bv Virusrensningsmetoder
CA2586107A1 (en) 2004-11-03 2006-05-18 Introgen Therapeutics Inc. A novel method for the production and purification of adenoviral vectors
US7851218B2 (en) 2004-12-13 2010-12-14 Schering Corporation Cell lines for production of replication-defective adenovirus
CA2602944C (en) 2005-04-11 2015-08-11 Crucell Holland B.V. Virus purification using ultrafiltration
CN1961961B (zh) * 2005-11-11 2010-05-26 深圳市源兴生物医药科技有限公司 一种药物制剂及其制备方法
US20070249043A1 (en) 2005-12-12 2007-10-25 Mayall Timothy P Adenoviral expression vectors
RU2484135C2 (ru) * 2006-04-20 2013-06-10 Вайет Способ очистки, предназначенный для получения очищенного вируса везикулярного стоматита из клеточной культуры
EP2350268B1 (en) 2008-11-03 2014-12-24 Crucell Holland B.V. Method for the production of adenoviral vectors
LT3421603T (lt) 2009-05-02 2022-01-10 Genzyme Corporation Genų terapija, skirta neurodegeneraciniams sutrikimams
NZ601424A (en) 2010-02-15 2014-07-25 Crucell Holland Bv Method for the production of ad26 adenoviral vectors
US8771709B2 (en) 2010-09-20 2014-07-08 Crucell Holland B.V. Therapeutic vaccination against active Tuberculosis
WO2012041669A1 (en) 2010-09-27 2012-04-05 Crucell Holland B.V. Heterologous prime boost vaccination regimen against malaria
TW201233802A (en) 2010-12-02 2012-08-16 Oncolytics Biotech Inc Liquid viral formulations
KR102023207B1 (ko) 2010-12-02 2019-11-25 온콜리틱스 바이오테크 인코포레이티드 동결건조 바이러스 제형
CN103492557B (zh) * 2011-04-29 2015-07-29 昂科利蒂克斯生物科技公司 使用凝胶渗透色谱法纯化病毒的方法
US8932607B2 (en) 2012-03-12 2015-01-13 Crucell Holland B.V. Batches of recombinant adenovirus with altered terminal ends
KR102044051B1 (ko) 2012-03-12 2019-11-12 얀센 백신스 앤드 프리벤션 비.브이. 터미널 말단이 변경된 재조합 아데노바이러스의 배치
US9125870B2 (en) 2012-03-22 2015-09-08 Crucell Holland B.V. Vaccine against RSV
NZ630753A (en) 2012-03-22 2016-12-23 Janssen Vaccines & Prevention Bv Vaccine against rsv
TR201902513T4 (tr) 2013-04-25 2019-03-21 Janssen Vaccines & Prevention Bv Stabilize edilmiş çözünebilir prefüzyon RSV F polipeptitleri.
EP3010931B1 (en) 2013-06-17 2018-06-13 Janssen Vaccines & Prevention B.V. Stabilized soluble pre-fusion rsv f polypeptides
SG11201609908VA (en) * 2014-05-28 2016-12-29 Agency Science Tech & Res Virus reduction method
WO2016166088A1 (en) 2015-04-14 2016-10-20 Janssen Vaccines & Prevention B.V. Recombinant adenovirus expressing two transgenes with a bidirectional promoter
ES2839880T3 (es) 2015-07-07 2021-07-06 Janssen Vaccines & Prevention Bv Vacuna contra el VRS
CA2991540A1 (en) 2015-07-07 2017-01-12 Janssen Vaccines & Prevention B.V. Stabilized soluble pre-fusion respiratory syncytial sirus polypeptides
PT3439672T (pt) 2016-04-05 2021-02-24 Janssen Vaccines & Prevention Bv Proteína f do rsv pré-fusão solúvel e estabilizada para uso na profilaxia de infeção por rsv
EP3439694A1 (en) 2016-04-05 2019-02-13 Janssen Vaccines & Prevention B.V. Vaccine against rsv
KR102421049B1 (ko) 2016-05-30 2022-07-15 얀센 백신스 앤드 프리벤션 비.브이. 안정화된 융합-전 rsv f 단백질
US11001858B2 (en) 2016-06-20 2021-05-11 Janssen Vaccines & Prevention B.V. Potent and balanced bidirectional promoter
US10744196B2 (en) 2016-07-14 2020-08-18 Janssen Vaccines & Prevention B.V. HPV vaccines
US11229692B2 (en) 2017-05-17 2022-01-25 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against RSV infection
WO2018210871A1 (en) 2017-05-17 2018-11-22 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against rsv infection
WO2019021305A1 (en) * 2017-07-24 2019-01-31 Ella Foundation VACCINE AGAINST FOOT AND MOUTH DISEASE
KR20200053518A (ko) 2017-09-15 2020-05-18 얀센 백신스 앤드 프리벤션 비.브이. Rsv에 대한 면역의 안전한 유도를 위한 방법
SG11202104522UA (en) 2018-11-13 2021-05-28 Janssen Vaccines & Prevention Bv Stabilized pre-fusion rsv f proteins
CN114173827B (zh) * 2019-06-28 2025-01-28 武田药品工业株式会社 腺相关病毒纯化方法
EP4097122A4 (en) 2020-01-31 2024-07-17 Beth Israel Deaconess Medical Center, Inc. COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUS INFECTION - SARS-COV-2 VACCINES
MA71423A (fr) * 2020-03-19 2025-04-30 Trizell Ltd. Système de stockage de virus sensible à la température
EP4294436A1 (en) 2021-02-19 2023-12-27 Janssen Vaccines & Prevention B.V. Stabilized pre-fusion rsv fb fantigens
WO2023020556A1 (zh) * 2021-08-17 2023-02-23 上海行深生物科技有限公司 病毒制剂、用于配制病毒制剂的溶液及其用途
WO2023020939A1 (en) 2021-08-17 2023-02-23 Janssen Pharmaceuticals, Inc. Sars-cov-2 vaccines
WO2023111725A1 (en) 2021-12-14 2023-06-22 Janssen Pharmaceuticals, Inc. Sars-cov-2 vaccines

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE299213C (id) *
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
GB1575155A (en) * 1978-04-11 1980-09-17 Merck & Co Inc Vaccine stabilizer
BE866330A (fr) * 1978-04-25 1978-10-25 Merck & Co Inc Procede de fabrication d'un agent de stabilisation de vaccin
US5532220A (en) 1987-08-31 1996-07-02 The Regents Of The University Of California Genetic mechanisms of tumor suppression
DD299213A7 (de) * 1988-05-04 1992-04-09 Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De Verfahren zur stabilisierung eines lebendvirusimpfstoffes gegen temperatureinwirkung
DD295927A5 (de) * 1988-05-06 1991-11-14 Saechsisches Serumwerk Gmbh Dresden, Immobilisiertes immunologisch aktives reagens
EP1637608B1 (en) 1993-10-25 2009-07-22 CANJI, Inc. Recombinant adenoviral vector and methods of use
KR100368686B1 (ko) * 1994-12-29 2003-12-01 주식회사 엘지생명과학 수크로즈를이용한세포와바이러스의분리방법
FR2742756B1 (fr) * 1995-12-22 1998-04-03 Pasteur Merieux Serums Vacc Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
US5789244A (en) 1996-01-08 1998-08-04 Canji, Inc. Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems

Also Published As

Publication number Publication date
ES2272053T3 (es) 2007-04-16
CN101164623B (zh) 2012-11-14
NO20004104D0 (no) 2000-08-16
DE69933433T2 (de) 2007-08-23
HK1028416A1 (en) 2001-02-16
CN1297478A (zh) 2001-05-30
EP1526174A3 (en) 2005-08-31
PL342847A1 (en) 2001-07-16
AR063315A2 (es) 2009-01-21
AU757976B2 (en) 2003-03-13
JP4358434B2 (ja) 2009-11-04
NO20004104L (no) 2000-10-17
CN100374551C (zh) 2008-03-12
ATE478945T1 (de) 2010-09-15
TWI232107B (en) 2005-05-11
EP1526173A3 (en) 2005-08-10
EP1526174A2 (en) 2005-04-27
JP2010213727A (ja) 2010-09-30
CA2320419C (en) 2011-02-08
WO1999041416A3 (en) 1999-11-18
PL197747B1 (pl) 2008-04-30
HU226015B1 (en) 2008-02-28
KR100862169B1 (ko) 2008-10-09
EP1054955A2 (en) 2000-11-29
EP1741777A1 (en) 2007-01-10
ATE371020T1 (de) 2007-09-15
EP1526173A2 (en) 2005-04-27
KR20090038927A (ko) 2009-04-21
KR20080065615A (ko) 2008-07-14
HK1097413A1 (en) 2007-06-22
AU2653899A (en) 1999-08-30
AR063314A2 (es) 2009-01-21
KR20080065614A (ko) 2008-07-14
CA2320419A1 (en) 1999-08-19
DE69936948T2 (de) 2008-05-15
CN101164623A (zh) 2008-04-23
KR20090127947A (ko) 2009-12-14
CO4820440A1 (es) 1999-07-28
JP2002503484A (ja) 2002-02-05
SK11842000A3 (sk) 2001-05-10
IL137510A0 (en) 2001-07-24
EP1526173B1 (en) 2012-11-21
HK1073481A1 (en) 2005-10-07
EP1741777B1 (en) 2010-08-25
HUP0100670A3 (en) 2003-10-28
KR100991683B1 (ko) 2010-11-04
DK1054955T3 (da) 2007-01-15
DE69936948D1 (de) 2007-10-04
KR100918187B1 (ko) 2009-09-22
EP1054955B1 (en) 2006-10-04
MY141641A (en) 2010-05-31
JP2006166925A (ja) 2006-06-29
DE69942708D1 (de) 2010-10-07
EP1526174B1 (en) 2007-08-22
PT1054955E (pt) 2007-01-31
AR020054A1 (es) 2002-04-10
PE20000265A1 (es) 2000-04-25
IL137510A (en) 2012-10-31
BR9908015A (pt) 2001-04-24
ATE341614T1 (de) 2006-10-15
CA2723040A1 (en) 1999-08-19
HUP0100670A2 (hu) 2001-06-28
KR100912362B1 (ko) 2009-08-19
KR101018992B1 (ko) 2011-03-07
ES2290613T3 (es) 2008-02-16
KR20010072547A (ko) 2001-07-31
WO1999041416A2 (en) 1999-08-19
DE69933433D1 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
ID28298A (id) Komposisi yang mengandung virus dan metode untuk memekatkan preparat-preparat virus
ID20996A (id) Lembaran penyeka dan metode untuk memproduksinya
ID26104A (id) Metoda-metoda dan bahan-bahan untuk mengobati dan mencegah radang jaringan mukosa
FI20070005L (fi) L-nukleosidejä hepatiitti-B-viruksen ja Epstein-Barr-viruksen hoitamiseksi
ID30322A (id) HETEROSIKLIK YANG MENGANDUNG INHIBITOR BIFENIL aP2 DAN METODANYA
ID22873A (id) Senyawa-senyawa heterosiklik dan pemakaiannya untuk menginhibisi b-amyloid peptida
ID22957A (id) Senyawa dan penggunaannya
SG10201710373RA (en) Methods and compositions for treating hepatitis c virus
ID22389A (id) Komposisi dan metode untuk menurunkan hipertensi okuler
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID17437A (id) Metoda dan komposisi untuk membuat kulit terang
ID26964A (id) Komposisi dan metode untuk pengaturan pengaktifan limfosit
ID18662A (id) Metoda pemanggangan dan alat berkaitan dengan itu
ID24196A (id) Komposisi dan penggunaan
ID28576A (id) Aparatus pelindung untuk penggunaan dalam hubungannya dengan perkakas sumuran dan metode untuk perlindungan kumparan
ID28728A (id) Komposisi dan proses pengkrepan
IS5510A (is) Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða
ID19548A (id) Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin
ID28752A (id) Metode-metode dan komposisi-komposisi sanitasi
ID23809A (id) Komposisi-komposisi alginat yang dapat dituang
ID30135A (id) Komposisi-komposisi dan metode-metode untuk mengontrol serangga-serangga
ID29536A (id) Komposisi berair dapat dituang yang mengandung boron dan penyiapannya
PT1137632E (pt) Tioureias inibidoras de virus herpes
BR9711714A (pt) Composi-Æo detergente granulada e processo para prepar -la
DE69817681D1 (de) Filter zur Virusentfernung